Betel quid chewing, which contributes high concentration of
safrole in saliva, is a popular oral habit in Taiwan.
Safrole is a documented rodent hepatocarcinogen, yet its hepatocarcinogenic potential in human is not known. Here, we used LC/ESI-ITMS(n) and LC/QTOF-MS confirmed
safrole-
dGMP as reference standard to detect the
safrole-
DNA adduct in hepatic tissues from
HBsAg-/HCV-seronegative
hepatocellular carcinoma patients by (32)P-postlabeling. We first synthesized and confirmed
safrole-
dGMP by LC/MS. Two isomeric
safrole-dGMPs were characterized as N(2)-(trans-isosafrol-3'-yl)
deoxyguanosine and N(2)-(safrol-1'-yl)
deoxyguanosine. This technique was able to detect hepatic
safrole-
DNA adduct in mice that were treated with
safrole but not sensitive enough to detect
safrole-
DNA adduct in human samples. Using the nuclease P1 version of the (32)P-postlabeling technique, we detected the presence of
safrole-
DNA adduct in two out of 28 hepatic tissues from
hepatocellular carcinoma patients, and only these two patients had a history of betel quid chewing lasting more than 10 years. From co-chromatography with the mass confirmed
safrole-dGMPs, this
safrole-
DNA adduct was identified as N(2)-(trans-isosafrol-3'-yl)
deoxyguanosine. These results suggest that betel quid-containing
safrole might be involved in the pathogenesis of
hepatocellular carcinoma in human beings and LC/MS has the potential to identify
DNA adducts in clinical samples.